Leukotriene receptor antagonists.
Altinger
J A
JA
Department of Cardiothoracic Surgery, UCSF Stanford Healthcare 94305, USA.
D000085:Acetates / Q000276:immunology / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000276:immunology / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D003521:Cyclopropanes; D006801:Humans; D006918:Hydroxyurea / Q000031:analogs & derivatives / Q000276:immunology / Q000627:therapeutic use; D007211:Indoles; D020024:Leukotriene Antagonists / Q000276:immunology / Q000627:therapeutic use*; D015289:Leukotrienes / Q000276:immunology; D048448:Phenylcarbamates; D011804:Quinolines / Q000276:immunology / Q000627:therapeutic use; D013440:Sulfides; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000276:immunology / Q000627:therapeutic use
D000085:Acetates; D018927:Anti-Asthmatic Agents; D003521:Cyclopropanes; D007211:Indoles; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D048448:Phenylcarbamates; D011804:Quinolines; D013440:Sulfides; D013449:Sulfonamides; D014105:Tosyl Compounds; C093875:montelukast; C063449:zileuton; D006918:Hydroxyurea; C062735:zafirlukast